Article Details

Orasis Announces Initiation of Phase 2b Clinical Study of CSF-1 for the Treatment of Presbyopia

Retrieved on: 2019-03-26 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

Orasis Announces Initiation of Phase 2b Clinical Study of CSF-1 for the Treatment of Presbyopia. View article details on hiswai:

Excerpt

<div>... Visionary Ventures, <b>Sequoia Capital</b>, SBI (Japan) Innovation Fund, LifeSci Venture Partners, Maverick Ventures Israel, and other private investors.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up